Xilio Therapeutics | 4:持股变动声明-高管 Frankenfield Christopher James
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(4%),Takeda Ventures, Inc(4%)
Xilio Therapeutics | 4:持股变动声明-董事 Bonstein Sara
Xilio Therapeutics | 4:持股变动声明-董事 Xu Yuan
Xilio Therapeutics | 4:持股变动声明-董事 ROSS ROBERT W.
Xilio Therapeutics | 4:持股变动声明-董事 Rossi Christina
Xilio Therapeutics | 4:持股变动声明-董事 Clancy Paul J
Xilio Therapeutics | 4:持股变动声明-董事 Curran Daniel J.
Xilio Therapeutics | 4:持股变动声明-董事 Shannon James Samuel
Xilio Therapeutics | 4:持股变动声明-董事 Brennan Aoife
Xilio Therapeutics | 3:首次持股声明-董事 Shannon James Samuel
Xilio Therapeutics | 3:首次持股声明-董事 Brennan Aoife
Xilio Therapeutics | 4:持股变动声明-高管 Russo Rene
Xilio Therapeutics | 4:持股变动声明-高管 Frankenfield Christopher James
Xilio Therapeutics | 4:持股变动声明-高管 Brennan Kevin M.
Xilio Therapeutics | 4:持股变动声明-高管 Luptakova Katarina
Xilio Therapeutics | SC 13G:超过5%持股股东披露文件-Gilead Sciences, Inc.(19.9%)
Xilio Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%)等
Xilio Therapeutics | 4:持股变动声明-股东 GILEAD SCIENCES, INC.
Xilio Therapeutics | 3:首次持股声明-股东 GILEAD SCIENCES, INC.
暂无数据